low-grade dysplasia
AGA Issues Updated Guideline on Endoscopic Eradication Therapy for BE
The AGA recently published a clinical practice guideline on endoscopic eradication therapy for Barrett’s ...
OCTOBER 1, 2024

Where Does Cryotherapy Belong in the Clinical Toolbox for Barrett’s Esophagus?
Cryotherapy can be considered as an alternative to radiofrequency ablation in the treatment of Barrett’s ...
APRIL 23, 2024

The Role of Biomarkers In the Management Of Barrett’s Esophagus
It is well established that selected patients with high-grade dysplasia (HGD)/esophageal adenocarcinoma (EAC) ...
OCTOBER 26, 2020

The Role of Biomarkers In the Management of Barrett’s Esophagus
We have yet to develop selection criteria to determine which patients with Barrett’s esophagus and either no ...
JULY 24, 2020

Basal Crypt Dysplasia In Barrett’s Esophagus
Research supports the concept that crypt dysplasia falls on the dysplasia pathway such that Barrett’s ...
SEPTEMBER 23, 2019

Tales of the Crypts: Brush Biopsy IDs Atypical Cells in BE
Crypt dysplasia in patients with Barrett’s esophagus is associated with a high rate of histologic ...
FEBRUARY 11, 2019

Online CRC Risk Tool Guides Care For Ulcerative Colitis Patients
Vienna—A novel risk assessment tool for patients with colorectal cancer and ulcerative colitis and low-grade ...
APRIL 11, 2018
